Cargando…
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain
Estimating neutralizing activity in vaccinees is crucial for predicting the protective effect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the plaque reduction neutralization test (PRNT) requires a biosafety level 3 facility, it would be advantageous if surrogate virus ne...
Autores principales: | Lee, Beomki, Ko, Jae-Hoon, Lee, Kyoung Hwa, Kim, Yong Chan, Song, Young Goo, Park, Yoon Soo, Baek, Yae Jee, Ahn, Jin Young, Choi, Jun Yong, Song, Kyoung-Ho, Kim, Eu Suk, Bae, Seongman, Kim, Sung-Han, Jeong, Hye Won, Kim, Shin-Woo, Kwon, Ki Tae, Kim, Su-Hwan, Jeong, Hyeonji, Kim, Byoungguk, Kim, Sung Soon, Choi, Won Suk, Peck, Kyong Ran, Kang, Eun-Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769750/ https://www.ncbi.nlm.nih.gov/pubmed/36250875 http://dx.doi.org/10.1128/spectrum.02669-22 |
Ejemplares similares
-
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea
por: Nham, Eliel, et al.
Publicado: (2022) -
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
por: Bae, Seongman, et al.
Publicado: (2022) -
Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea
por: Ahn, Jin Young, et al.
Publicado: (2023) -
Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test
por: Lee, Hee-Jung, et al.
Publicado: (2014) -
Performance of STANDARD™ M10 SARS-CoV-2 Assay for the Diagnosis of COVID-19 from a Nasopharyngeal Swab
por: Ham, Sin Young, et al.
Publicado: (2022)